Masaaki Mori

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

Shumpei Yokota, Tomoyuki Imagawa, Masaaki Mori et al. · The Lancet · 2008 · 797 citations

Medicine, Clinical Sciences, Pharmacotherapy +8

Therapeutic efficacy of humanized recombinant anti–interleukin‐6 receptor antibody in children with systemic‐onset juvenile idiopathic arthritis

Shumpei Yokota, Takako Miyamae, Tomoyuki Imagawa et al. · Arthritis & Rheumatism · 2005 · 372 citations

Medicine, Pediatrics, Pharmacotherapy +13

2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases

Yoshiya Tanaka, Masataka Kuwana, Takao Fujii et al. · Modern Rheumatology · 2020 · 134 citations · Full text

Medicine, Dermatology, Immunology +16

Characterization of Crohn disease in X-linked inhibitor of apoptosis–deficient male patients and female symptomatic carriers

Claire Aguilar, Christelle Lenoir, Nathalie Lambert et al. · Journal of Allergy and Clinical Immunology · 2014 · 120 citations

Life Sciences, Immunology, Pathology +16

Predictors of coronary artery lesions after intravenous γ-globulin treatment in Kawasaki disease

Masaaki Mori, Tomoyuki Imagawa, Kiyoshi Yasui et al. · The Journal of Pediatrics · 2000 · 117 citations

Medicine, Cardiology, Pharmacotherapy +9